ABCA1 and Impaired glucose tolerance: An earlier study on mice reported that the targeted deletion of β-cell ABCA1 caused an accumulation of cholesterol in islets as well as reduced glucose-stimulated insulin secretion (GSIS) and impaired glucose tolerance [38].